Pay in 4 interest-free payments of $5.83 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
(2020) 53:e12909
The studies had similar outcomes: DPP-4 inhibition and sulfonylurea both reduced HbA1c, DPP-4 inhibition had no weight gain, which on the contrary was seen with sulfonylurea, and there was a marked difference in hypoglycemia episodes
Targeting lung cancer with clinically relevant EGFR mutations using anti-EGFR RNA aptamer
[PMC free article][PubMed] [CrossRef] Winter SC
We are committed to helping you achieve your health goals and improve your overall well-being
Dymek M, Sikora E, et al
US$ 20.24
US$ 26.38
US$ 29.16
US$ 24.44
